DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zyprexa (Olanzapine) - Published Studies

 
 



Zyprexa Related Published Studies

Well-designed clinical trials related to Zyprexa (Olanzapine)

A double-blind randomized Phase II study of olanzapine 10 mg versus 5 mg for emesis induced by highly emetogenic chemotherapy. [2015]

Sleep architecture and cognitive changes in olanzapine-treated patients with depression: a double blind randomized placebo controlled trial. [2014]

Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study. [2014]

Long-term effects of asenapine or olanzapine in patients with persistent negative symptoms of schizophrenia: a pooled analysis. [2013]

A randomized controlled trial of olanzapine improving memory deficits in Han Chinese patients with first-episode schizophrenia. [2013]

Pharmacokinetic evaluation of olanzapine + fluoxetine for the treatment of bipolar depression. [2013]

Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial. [2013]

Aripiprazole versus olanzapine in the treatment of schizophrenia: a clinical study from India. [2013]

Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis. [2012]

Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression. [2012]

Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study. [2012]

Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics. [2012]

A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study. [2011.10]

Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia. [2011.09.23]

Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial. [2011.09]

A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP). [2011.09]

Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study. [2011.09]

The GiSAS study: rationale and design of a pragmatic randomized controlled trial on aripiprazole, olanzapine and haloperidol in the long-term treatment of schizophrenia. [2011.09]

Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes. [2011.08.15]

Impact of olanzapine or risperidone treatment on insulin sensitivity in schizophrenia or schizoaffective disorder. [2011.08]

A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa. [2011.06]

Genetic variation in CYP3A43 explains racial difference in olanzapine clearance. [2011.06]

Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison. [2011.06]

Assessment of treatment algorithms including amantadine, metformin, and zonisamide for the prevention of weight gain with olanzapine: a randomized controlled open-label study. [2011.05.17]

Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia. [2011.05]

Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine. [2011.04]

Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week open-label extension phase and both phases of a randomized controlled trial. [2011.03]

Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia. [2011.02.15]

Olanzapine vs. risperidone in treating aggressive behaviours in adults with intellectual disability: a single blind study. [2011.02]

Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). [2011.02]

Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes. [2011.02]

An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia. [2011.01.15]

Dose correspondence between olanzapine long-acting injection and oral olanzapine: recommendations for switching. [2011.01]

A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers. [2011]

Bioequivalence evaluation of two oral formulations of quetiapine fumarate in healthy volunteers. [2011]

A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa. [2011]

Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics. [2011]

Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. [2011]

The effect of Olanzapine and Sertraline on personality disorder in patients with methadone maintenance therapy. [2010.12]

Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controlled clinical trials. [2010.12]

Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophrenia. [2010.12]

Beneficial effect of the insulin sensitizer (HSP inducer) BGP-15 on olanzapine-induced metabolic disorders. [2010.11.20]

Symptoms predicting remission after divalproex augmentation with olanzapine in partially nonresponsive patients experiencing mixed bipolar I episode: a post-hoc analysis of a randomized controlled study. [2010.11.02]

Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study. [2010.10]

Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. [2010.09]

Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice. [2010.09]

Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week open-label extension phase and both phases of a randomized controlled trial. [2010.08.24]

Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia. [2010.07]

Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study. [2010.07]

Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes. [2010.06.09]

Risperidone versus olanzapine for the treatment of delirium. [2010.06]

Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder. [2010.06]

Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan. [2010.06]

Olanzapine: in adolescents with schizophrenia or bipolar I disorder. [2010.05.01]

Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial. [2010.05]

Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression. [2010.05]

Olanzapine vs. lithium in management of acute mania. [2010.05]

A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia. [2010.04.20]

A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. [2010.04.20]

Orally disintegrating and oral standard olanzapine tablets similarly elevate the homeostasis model assessment of insulin resistance index and plasma triglyceride levels in 12 healthy men: a randomized crossover study. [2010.04.20]

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone. [2010.03.24]

Modeling the effectiveness of paliperidone ER and olanzapine in schizophrenia: meta-analysis of 3 randomized, controlled clinical trials. [2010.03]

Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial. [2010.03]

Olanzapine versus haloperidol in the management of borderline personality disorder: a randomized double-blind trial. [2010.02]

Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia. [2010.02]

Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients. [2010.01.30]

Short-term treatment with olanzapine does not modulate gut hormone secretion: olanzapine disintegrating versus standard tablets. [2010.01]

Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophrenia. [2010]

Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia. [2010]

Ezogabine: a novel antiepileptic as adjunctive therapy for partial onset seizures. [2010]

A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. [2010]

Olanzapine: in adolescents with schizophrenia or bipolar I disorder. [2010]

Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies. [2010]

Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder. [2010]

Olanzapine versus haloperidol in the management of borderline personality disorder: a randomized double-blind trial. [2010]

Modeling the effectiveness of paliperidone ER and olanzapine in schizophrenia: meta-analysis of 3 randomized, controlled clinical trials. [2010]

Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized, Double-blind, Placebo-Controlled Trial. [2010]

Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients. [2010]

Olanzapine vs. lithium in management of acute mania. [2010]

Asenapine versus olanzapine in acute mania: a double-blind extension study. [2009.12]

Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study. [2009.11]

Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. [2009.11]

Mifepristone treatment of olanzapine-induced weight gain in healthy men. [2009.10]

Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder. [2009.10]

Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting. [2009.09.23]

Olanzapine-Divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. [2009.09.22]

A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). [2009.08]

Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico. [2009.08]

A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study. [2009.08]

Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction? [2009.07]

Olanzapine compared to quetiapine in adolescents with a first psychotic episode. [2009.07]

Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. [2009.07]

Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. [2009.07]

Ziprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial. [2009.06.19]

Olanzapine shifts the temporal relationship between the daily acrophase of serum prolactin and cortisol concentrations rhythm in healthy men. [2009.06]

Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis. [2009.05]

Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. [2009.05]

Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol. [2009.05]

An exploration of the effect of modafinil on olanzapine associated weight gain in normal human subjects. [2009.04.01]

Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients. [2009.04]

A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone. [2009.04]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017